BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23580180)

  • 1. Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.
    Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Tumour Biol; 2013 Aug; 34(4):2109-17. PubMed ID: 23580180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
    Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Int J Colorectal Dis; 2013 Jan; 28(1):9-18. PubMed ID: 22733437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of metastasis-related tumor markers in colorectal cancer].
    Wan XB; Pan ZZ; Ren YK; Ding PR; Chen G; Wan DS
    Ai Zheng; 2009 Sep; 28(9):950-4. PubMed ID: 19728913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
    Martins SF; Garcia EA; Luz MA; Pardal F; Rodrigues M; Filho AL
    Cancer Genomics Proteomics; 2013; 10(2):55-67. PubMed ID: 23603341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
    Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
    APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
    Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
    World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis.
    Jayasinghe C; Simiantonaki N; Michel-Schmidt R; Kirkpatrick CJ
    Oncol Rep; 2009 Nov; 22(5):1093-100. PubMed ID: 19787226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer.
    D'Haene N; Koopmansch C; Van Eycke YR; Hulet F; Allard J; Bouri S; Rorive S; Remmelink M; Decaestecker C; Maris C; Salmon I
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.
    Chen L; Jiang B; Wang Z; Liu M; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Cui M; Su X
    Clin Transl Oncol; 2014 Mar; 16(3):285-92. PubMed ID: 23860725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
    White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
    Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer.
    Kluftinger AM; Robinson BW; Quenville NF; Finley RJ; Davis NL
    Surg Oncol; 1992 Feb; 1(1):97-105. PubMed ID: 1285215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of lymphangiogenesis to progression of colorectal cancer].
    Wang TB; Huang YH; Lan P; Song XM; Wang JP
    Ai Zheng; 2005 Oct; 24(10):1276-9. PubMed ID: 16219148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis.
    Tremmel M; Matzke A; Albrecht I; Laib AM; Olaku V; Ballmer-Hofer K; Christofori G; Héroult M; Augustin HG; Ponta H; Orian-Rousseau V
    Blood; 2009 Dec; 114(25):5236-44. PubMed ID: 19773544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between lymphatic endothelial markers and lymph node status or N-staging of colorectal cancer.
    Zhang XM; Han WX; Wang HY; He Q
    World J Surg Oncol; 2017 Nov; 15(1):204. PubMed ID: 29162097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].
    Zhang YH; Diao L; Yang Q; Duo J; Liu YX; Liu SX; Yao X
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):752-6. PubMed ID: 21163065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.